Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Energy Fuels Aktie: Achtung, Aufholpotenzial! (Aktiencheck) +++ ENERGY FUELS Aktie -3,11%

COLLPLANT Aktie

>COLLPLANT Performance
1 Woche: 0%
1 Monat: -74,1%
3 Monate: -51,3%
6 Monate: -69,8%
1 Jahr: -78,2%
laufendes Jahr: -69,8%
>COLLPLANT Aktie
Name:  COLLPLANT BIOTECHNOLOGIES
Land:  Israel
Sektor:  Gesundheit
ISIN/ Wkn:  IL0004960188 / A1CY27
Symbol/ Ticker:  CPT (Frankfurt) / CLGN (NASDAQ)
Kürzel:  FRA:CPT, ETR:CPT, CPT:GR, NASDAQ:CLGN
Index:  -
Webseite:  https://collplant.com/
Marktkapitalisierung:  14.02 Mio. EUR
Umsatz:  2.14 Mio. EUR
EBITDA:  -11.75 Mio. EUR
Gewinn je Aktie:  -0.9 EUR
Schulden:  2.46 Mio. EUR
Liquide Mittel:  9.29 Mio. EUR
Umsatz-/ Gewinnwachstum:  1% / -
KGV/ KGV lG:  - / -
KUV/ KBV/ PEG:  4.86 / 0.97 / -
Gewinnm./ Eigenkapitalr.:  - / -75.27%
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Insiderhandel:  -
Suchwörter:  COLLPLANT
Letzte Datenerhebung:  05.07.25
>COLLPLANT Eigentümer
Aktien: 11.45 Mio. St.
f.h. Aktien: 7.65 Mio. St.
Insider Eigner: 10.16%
Instit. Eigner: 12.23%
>COLLPLANT Peer Group

 
17.06.25 - 22:27
CollPlant files to sell 1.27M ordinary shares for holders (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
09.06.25 - 13:51
CollPlant shares rises on expanded partnership with STEMCELL Technologies (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
09.06.25 - 13:45
CollPlant broadens collaboration with STEMCELL Technologies (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
09.06.25 - 13:03
COLLPLANT BROADENS ITS COLLABORATION WITH STEMCELL TECHNOLOGIES (PR Newswire)
 
CollPlant's proprietary rhCollagen to be used in clinical and commercial applications REHOVOT, Israel, June 9, 2025 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its......
04.06.25 - 13:03
COLLPLANT BIOTECHNOLOGIES ANNOUNCES EUROPEAN PATENT ALLOWANCE SECURED FOR ITS COLLAGEN-BASED FORMULATIONS USABLE AS SOFT TISSUE FILLERS AND IMPLANTS (PR Newswire)
 
- Further protection granted in key territory applying to the significant and growing aesthetic and reconstructive markets - REHOVOT, Israel, June 4, 2025 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative......
30.05.25 - 13:39
CollPlant Biotechnologies shares slide after announces capital raise $3.6M through registered direct offering (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
30.05.25 - 13:01
COLLPLANT BIOTECHNOLOGIES ANNOUNCES $3.6 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES (PR Newswire)
 
REHOVOT, Israel, May 30, 2025 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived, rhCollagen for tissue regeneration and medical aesthetics, today......
28.05.25 - 13:06
CollPlant Biotechnologies GAAP EPS of -$0.13 misses by $0.09, revenue of $2.06M misses by $0.6M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
28.05.25 - 13:03
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE (PR Newswire)
 
- In Q1 following a development achievement, CollPlant received a $2 million payment from AbbVie – - Advancement of regenerative breast implant program continues; encouraging findings continue to be observed - REHOVOT, Israel, May 28, 2025 /PRNewswire/ -- CollPlant Biotechnologies......
14.05.25 - 13:00
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FIRST QUARTER FINANCIAL RESULTS (PR Newswire)
 
REHOVOT, Israel, May 14, 2025 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived, rhCollagen for tissue regeneration and medical aesthetics, today......
27.03.25 - 01:03
Collplant plans clinical trials for dermal filler and advances regenerative implants (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
26.03.25 - 13:18
CollPlant Biotechnologies Non-GAAP EPS of -$1.30, revenue of $0.52M beats by $0.07M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
19.03.25 - 12:03
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION (PR Newswire)
 
Conference call to be held on Wednesday, March 26, 2025 at 10:00 a.m. U.S. EST REHOVOT, Israel, March 19, 2025 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its......
27.11.24 - 15:40
Collplant Biotechnologies Ltd reports results for the quarter ended September 30 - Earnings Summary (Reuters EN)
 
Collplant Biotechnologies Ltd reports results for the quarter ended September 30 - Earnings Summary Collplant Biotechnologies Ltd CLGN.OQ reported a quarterly adjusted loss of 38 cents​​ per share for the quarter ended September 30, identical to the same quarter last year. The mean expectation of two analysts for the quarter was for a loss of 28 cents per share....
27.11.24 - 13:02
COLLPLANT BIOTECHNOLOGIES REPORTS 2024 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE (PR Newswire)
 
-Promising results obtained from the pre-clinical study with CollPlant's commercial sized rhCollagen-based regenerative breast implants, demonstrating significant implant vascularization and rapid ingrowth of native tissue -Innovative breast implant technology designed to address a $3.0......
12.11.24 - 13:02
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION (PR Newswire)
 
- Conference call to be held on Wednesday, November 27, 2024 at 10:00 a.m. U.S. EST - REHOVOT, Israel, Nov. 12, 2024 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its......
21.08.24 - 20:19
CollPlant (CLGN), Stratasys Initiate Study for Breast Implants (Zacks)
 
CollPlant (CLGN) and Stratasys announce the initiation of a pre-clinical study to focus on the ability of implants to grow natural breast tissue and completely degrade over time....
20.08.24 - 13:12
CollPlant Biotechnologies GAAP EPS of -$0.33 misses by $0.06, revenue of $0.25M misses by $0.13M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
20.08.24 - 13:01
COLLPLANT BIOTECHNOLOGIES REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE (PR Newswire)
 
- Recently initiated a pre-clinical trial with CollPlant's rhCollagen-based regenerative breast implants, printed with Stratasys' Origin® 3D printer that are 200cc in volume - Breast implants could address a $3.0 billion market opportunity - Cash and cash equivalents balance as of June......
19.08.24 - 14:39
CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants (Business Wire)
 
Um den gesamten Artikel unter morningstar.com zu lesen, klicken Sie bitte auf die Überschrift...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Kein Kaiser kann, was unser ist, verschenken. - Friedrich Johann Christoph Schiller
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!